Symbol Therapeutics
Modified Protein for Treatment of Autoimmune Diseases
StartupSymbol Therapeutics is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 2021. Modified Protein for Treatment of Autoimmune Diseases. The company has raised a total of $3M across 1 funding round, currently at the Seed stage. Key investors include RMGP Biopharma Investment Fund, FutuRx. The company has 1-10 employees. Core technologies: Biologicals, Molecules.
With $3M in total funding, Symbol Therapeutics is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQNess Ziona
- Last Round$3M
- RMGP Biopharma Investment Fund
- FutuRx
What does Symbol Therapeutics do?
Symbol Therapeutics is a drug discovery company developing a novel immunoregulatory therapeutic protein, which is a modified form of the endogenous Semaphorin3A, for the treatment of systemic lupus erythematosus and other autoimmune diseases. Its proprietary modified protein is able to activate anti-inflammatory regulatory mechanisms and thereby restore normal immune homeostasis.
How much funding has Symbol Therapeutics raised?
Symbol Therapeutics has raised $3M in total funding across 1 rounds. The company is currently at the Seed stage. Key investors include RMGP Biopharma Investment Fund, FutuRx.
What sector is Symbol Therapeutics in?
Symbol Therapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Symbol Therapeutics located?
Symbol Therapeutics is based in Ness Ziona, Israel.